Pancreatic Cancer Research

ResearcherZhejiang Provincial People's HospitalActive in the last 2 years

Qiuran Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2171-9279; OpenAlex author ID A5038535866. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 4

  1. CD11b agonist GB1275 potentiates oncolytic bacterial therapy against pancreatic cancer in mouse tumor models Last author DOI 10.1038/s41467-026-76823-7↗
  2. Multi-omics and experimental validation identify USP54 as a prognostic deubiquitinase promoting pancreatic ductal adenocarcinoma progression within the immune … Co-author DOI 10.3389/fimmu.2026.1791707↗
  3. WTAP/IGF2BP3-mediated GBE1 expression accelerates the proliferation and enhances stemness in pancreatic cancer cells via upregulating c-Myc. Co-author DOI 10.1186/s11658-024-00611-8↗
  4. The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.927640↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zibo Yuan · 1 shared paper, 2026 · strength 0.39
  2. Di Cui · 1 shared paper, 2026 · strength 0.39
  3. Xiaoge Hu · 2 shared papers, 2022–2024 · strength 0.37
  4. Wen Fu · 2 shared papers, 2022–2024 · strength 0.37
  5. Bin Zhang · 1 shared paper, 2026 · strength 0.30
  6. Meng Guan · 1 shared paper, 2026 · strength 0.30
  7. Weiwei Jin · 1 shared paper, 2024 · strength 0.21
  8. Kangsheng Tu · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.